Status:
COMPLETED
Peripheral Stimulation Device to Improve Coronary Flow Reserve in Coronary Artery Disease
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Coronary Artery Disease
Ischemic Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of the PERCCAD Study is to investigate the effect of the gekoTM device (a non-invasive calf muscle stimulator approved for use to improve blood flow by Health Canada) on coronary blood flo...
Detailed Description
Angina pectoris or anginal equivalent dyspnoea are frequent symptoms related to impaired myocardial blood supply. The supply-demand imbalance that arises in the setting of coronary artery disease can ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18 - 80.
- Symptomatic coronary artery disease and already undergoing invasive angiographic assessment and percutaneous coronary intervention.
- Exclusion criteria:
- Significant valvular heart disease or left ventricular dysfunction.
- Contraindication to the administration of intracoronary adenosine.
- Latex allergy.
- Significant peripheral motor neuropathy.
Exclusion
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01853410
Start Date
July 1 2013
End Date
October 1 2015
Last Update
November 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A5A5